Average Co-Inventor Count = 5.60
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (12 from 410 patents)
2. Janssen Sciences Ireland Unlimited Company (3 from 60 patents)
3. Centocor, Inc. (2 from 144 patents)
4. Centocor Ortho Biotech Inc. (2 from 31 patents)
5. Other (1 from 832,680 patents)
6. Janssen Pharmaceutica Nv (1 from 2,076 patents)
7. Cna Development LLC (1 from 1 patent)
8. Pah USA 15 LLC (0 patent)
22 patents:
1. 12275770 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof
2. 12269870 - Antigen binding regions against fibronectin type III domains and methods of using the same
3. 11787875 - Materials and methods for improved single chain variable fragments
4. 11713345 - Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereof
5. 11603405 - Anti-CD3 antibodies and uses thereof
6. 11236155 - Antibodies to pyroglutamate amyloid-β and uses thereof
7. 11208464 - GDF15 fusion proteins and uses thereof
8. 11161897 - Antigen binding regions against fibronectin type III domains and methods of using the same
9. 10759854 - Interferon alpha and omega antibody antagonists
10. 10358491 - Interferon alpha and omega antibody antagonists
11. 10336812 - GDF15 fusion proteins and uses thereof
12. 10208113 - Interferon α and ω antibody antagonists
13. 10179808 - Kv1.3 antagonists and methods of use
14. 10155809 - Interferon alpha and omega antibody antagonists
15. 9902770 - Interferon alpha and omega antibody antagonists